Login
← Go Back
Novartis India
NOVARTIND · Retail > Trading · Chairman: C Snook · MD: Sanjay Murdeshwar · Listing date: Nov. 9, 2000 · Employees: 539 · Mumbai · http://www.novartis.in
Stock Price vs Company Growth
1d
5.2%
1w
12.4%
1m
51.9%
3m
61.0%
6m
83.3%
1y
40.9%
5y
21.8%
all
17.5%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,488 5.2%
890
1,495
Company Overview
Sales
354 Cr
Growth: -0.6%
Profit after Tax
93.2 Cr
Growth: -4.2%
Small Cap
3,674 Cr
P/E: 39.4x
Industry P/E: 26.5x
Fundamentals
Sales (Cr) ₹ 354
Growth -0.6%
EBITDA 26.6%
P/S 10.4x
Dividend 2.4%
P/E 39.4x
Book Value ₹ 331
PEG Ratio -62.2x
ROE 11.2%
P/B 4.5x
Shareholding Pattern
Institutions
Promoters
Novartis Ag
70.68 %
Others
Atul Limited
1.52 %
Iepf
0.47 %
Llp, Partnership Firm, Directors' Relative
0.14 %
Increase    Decrease    No change
Company Profile Detailed
As a science-based and patient-oriented healthcare company, it strives to be a global leader in growing areas of healthcare. Following a corporate transformation Novartis globally is focused on three divisions with global scale and innovation power - pharmaceuticals, eye care and generic medicines. This has strengthened the future growth prospects of the company.
Belongs to (8 Indices) view more
Investors (7)
abdul.ha...
iepf
total
Followers (1)
varsha96